Organogenesis | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Organogenesis | 10-K/A: Annual report (Amendment)
Organogenesis | 8-K: Current report
Organogenesis | 144: Notice of proposed sale of securities pursuant to Rule 144
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Cavorsi Robert
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Director Driscoll Michael Joseph
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Cavorsi Robert
Organogenesis | 10-K: FY2024 Annual Report
Organogenesis | 8-K: Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Cavorsi Robert
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Bilbo Patrick
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Montecalvo Antonio S.
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Grow Brian
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Freedman Lori
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Francisco David
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Director Quintero Gilberto
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Director Lustig Garrett
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Director Leibowitz Arthur S
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Director Korfin Michele Ilene
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Gillheeney Gary S.